Report cover image

Global Levothyroxine Sodium Tablets Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 190 Pages
SKU # APRC20362196

Description

Summary

According to APO Research, The global Levothyroxine Sodium Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Levothyroxine Sodium Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Levothyroxine Sodium Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Levothyroxine Sodium Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Levothyroxine Sodium Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Levothyroxine Sodium Tablets include Yangtze River Pharmaceutical (Group) Co., Ltd., Abbott, Shenzhen Zhonglian Pharmaceutical Co., Ltd., Sanofi, Merck, Pfizer, AstraZeneca, Otsuka Pharmaceutical and Nippon Shinyaku, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Levothyroxine Sodium Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Levothyroxine Sodium Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Levothyroxine Sodium Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Levothyroxine Sodium Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Levothyroxine Sodium Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Levothyroxine Sodium Tablets sales, projected growth trends, production technology, application and end-user industry.

Levothyroxine Sodium Tablets Segment by Company

Yangtze River Pharmaceutical (Group) Co., Ltd.
Abbott
Shenzhen Zhonglian Pharmaceutical Co., Ltd.
Sanofi
Merck
Pfizer
AstraZeneca
Otsuka Pharmaceutical
Nippon Shinyaku
Lannett Company
Levothyroxine Sodium Tablets Segment by Type

50μg
100μg
Levothyroxine Sodium Tablets Segment by Application

Retail Pharmacy
Hospital
Clinic
Others
Levothyroxine Sodium Tablets Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levothyroxine Sodium Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Levothyroxine Sodium Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levothyroxine Sodium Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Levothyroxine Sodium Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Levothyroxine Sodium Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Levothyroxine Sodium Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Levothyroxine Sodium Tablets Market by Type
1.2.1 Global Levothyroxine Sodium Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 50μg
1.2.3 100μg
1.3 Levothyroxine Sodium Tablets Market by Application
1.3.1 Global Levothyroxine Sodium Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Retail Pharmacy
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Levothyroxine Sodium Tablets Market Dynamics
2.1 Levothyroxine Sodium Tablets Industry Trends
2.2 Levothyroxine Sodium Tablets Industry Drivers
2.3 Levothyroxine Sodium Tablets Industry Opportunities and Challenges
2.4 Levothyroxine Sodium Tablets Industry Restraints
3 Global Market Growth Prospects
3.1 Global Levothyroxine Sodium Tablets Revenue Estimates and Forecasts (2020-2031)
3.2 Global Levothyroxine Sodium Tablets Revenue by Region
3.2.1 Global Levothyroxine Sodium Tablets Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Levothyroxine Sodium Tablets Revenue by Region (2020-2025)
3.2.3 Global Levothyroxine Sodium Tablets Revenue by Region (2026-2031)
3.2.4 Global Levothyroxine Sodium Tablets Revenue Market Share by Region (2020-2031)
3.3 Global Levothyroxine Sodium Tablets Sales Estimates and Forecasts 2020-2031
3.4 Global Levothyroxine Sodium Tablets Sales by Region
3.4.1 Global Levothyroxine Sodium Tablets Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Levothyroxine Sodium Tablets Sales by Region (2020-2025)
3.4.3 Global Levothyroxine Sodium Tablets Sales by Region (2026-2031)
3.4.4 Global Levothyroxine Sodium Tablets Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Levothyroxine Sodium Tablets Revenue by Manufacturers
4.1.1 Global Levothyroxine Sodium Tablets Revenue by Manufacturers (2020-2025)
4.1.2 Global Levothyroxine Sodium Tablets Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Levothyroxine Sodium Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Levothyroxine Sodium Tablets Sales by Manufacturers
4.2.1 Global Levothyroxine Sodium Tablets Sales by Manufacturers (2020-2025)
4.2.2 Global Levothyroxine Sodium Tablets Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Levothyroxine Sodium Tablets Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Levothyroxine Sodium Tablets Sales Price by Manufacturers (2020-2025)
4.4 Global Levothyroxine Sodium Tablets Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Levothyroxine Sodium Tablets Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Levothyroxine Sodium Tablets Manufacturers, Product Type & Application
4.7 Global Levothyroxine Sodium Tablets Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Levothyroxine Sodium Tablets Market CR5 and HHI
4.8.2 2024 Levothyroxine Sodium Tablets Tier 1, Tier 2, and Tier 3
5 Levothyroxine Sodium Tablets Market by Type
5.1 Global Levothyroxine Sodium Tablets Revenue by Type
5.1.1 Global Levothyroxine Sodium Tablets Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Levothyroxine Sodium Tablets Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Levothyroxine Sodium Tablets Revenue Market Share by Type (2020-2031)
5.2 Global Levothyroxine Sodium Tablets Sales by Type
5.2.1 Global Levothyroxine Sodium Tablets Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Levothyroxine Sodium Tablets Sales by Type (2020-2031) & (K Units)
5.2.3 Global Levothyroxine Sodium Tablets Sales Market Share by Type (2020-2031)
5.3 Global Levothyroxine Sodium Tablets Price by Type
6 Levothyroxine Sodium Tablets Market by Application
6.1 Global Levothyroxine Sodium Tablets Revenue by Application
6.1.1 Global Levothyroxine Sodium Tablets Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Levothyroxine Sodium Tablets Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Levothyroxine Sodium Tablets Revenue Market Share by Application (2020-2031)
6.2 Global Levothyroxine Sodium Tablets Sales by Application
6.2.1 Global Levothyroxine Sodium Tablets Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Levothyroxine Sodium Tablets Sales by Application (2020-2031) & (K Units)
6.2.3 Global Levothyroxine Sodium Tablets Sales Market Share by Application (2020-2031)
6.3 Global Levothyroxine Sodium Tablets Price by Application
7 Company Profiles
7.1 Yangtze River Pharmaceutical (Group) Co., Ltd.
7.1.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Comapny Information
7.1.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Business Overview
7.1.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Levothyroxine Sodium Tablets Product Portfolio
7.1.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments
7.2 Abbott
7.2.1 Abbott Comapny Information
7.2.2 Abbott Business Overview
7.2.3 Abbott Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Abbott Levothyroxine Sodium Tablets Product Portfolio
7.2.5 Abbott Recent Developments
7.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd.
7.3.1 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Comapny Information
7.3.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview
7.3.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Levothyroxine Sodium Tablets Product Portfolio
7.3.5 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Developments
7.4 Sanofi
7.4.1 Sanofi Comapny Information
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sanofi Levothyroxine Sodium Tablets Product Portfolio
7.4.5 Sanofi Recent Developments
7.5 Merck
7.5.1 Merck Comapny Information
7.5.2 Merck Business Overview
7.5.3 Merck Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Merck Levothyroxine Sodium Tablets Product Portfolio
7.5.5 Merck Recent Developments
7.6 Pfizer
7.6.1 Pfizer Comapny Information
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Pfizer Levothyroxine Sodium Tablets Product Portfolio
7.6.5 Pfizer Recent Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Comapny Information
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 AstraZeneca Levothyroxine Sodium Tablets Product Portfolio
7.7.5 AstraZeneca Recent Developments
7.8 Otsuka Pharmaceutical
7.8.1 Otsuka Pharmaceutical Comapny Information
7.8.2 Otsuka Pharmaceutical Business Overview
7.8.3 Otsuka Pharmaceutical Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Otsuka Pharmaceutical Levothyroxine Sodium Tablets Product Portfolio
7.8.5 Otsuka Pharmaceutical Recent Developments
7.9 Nippon Shinyaku
7.9.1 Nippon Shinyaku Comapny Information
7.9.2 Nippon Shinyaku Business Overview
7.9.3 Nippon Shinyaku Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Nippon Shinyaku Levothyroxine Sodium Tablets Product Portfolio
7.9.5 Nippon Shinyaku Recent Developments
7.10 Lannett Company
7.10.1 Lannett Company Comapny Information
7.10.2 Lannett Company Business Overview
7.10.3 Lannett Company Levothyroxine Sodium Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Lannett Company Levothyroxine Sodium Tablets Product Portfolio
7.10.5 Lannett Company Recent Developments
8 North America
8.1 North America Levothyroxine Sodium Tablets Market Size by Type
8.1.1 North America Levothyroxine Sodium Tablets Revenue by Type (2020-2031)
8.1.2 North America Levothyroxine Sodium Tablets Sales by Type (2020-2031)
8.1.3 North America Levothyroxine Sodium Tablets Price by Type (2020-2031)
8.2 North America Levothyroxine Sodium Tablets Market Size by Application
8.2.1 North America Levothyroxine Sodium Tablets Revenue by Application (2020-2031)
8.2.2 North America Levothyroxine Sodium Tablets Sales by Application (2020-2031)
8.2.3 North America Levothyroxine Sodium Tablets Price by Application (2020-2031)
8.3 North America Levothyroxine Sodium Tablets Market Size by Country
8.3.1 North America Levothyroxine Sodium Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Levothyroxine Sodium Tablets Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Levothyroxine Sodium Tablets Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Levothyroxine Sodium Tablets Market Size by Type
9.1.1 Europe Levothyroxine Sodium Tablets Revenue by Type (2020-2031)
9.1.2 Europe Levothyroxine Sodium Tablets Sales by Type (2020-2031)
9.1.3 Europe Levothyroxine Sodium Tablets Price by Type (2020-2031)
9.2 Europe Levothyroxine Sodium Tablets Market Size by Application
9.2.1 Europe Levothyroxine Sodium Tablets Revenue by Application (2020-2031)
9.2.2 Europe Levothyroxine Sodium Tablets Sales by Application (2020-2031)
9.2.3 Europe Levothyroxine Sodium Tablets Price by Application (2020-2031)
9.3 Europe Levothyroxine Sodium Tablets Market Size by Country
9.3.1 Europe Levothyroxine Sodium Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Levothyroxine Sodium Tablets Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Levothyroxine Sodium Tablets Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
9.3.9 Nordic Countries
10 China
10.1 China Levothyroxine Sodium Tablets Market Size by Type
10.1.1 China Levothyroxine Sodium Tablets Revenue by Type (2020-2031)
10.1.2 China Levothyroxine Sodium Tablets Sales by Type (2020-2031)
10.1.3 China Levothyroxine Sodium Tablets Price by Type (2020-2031)
10.2 China Levothyroxine Sodium Tablets Market Size by Application
10.2.1 China Levothyroxine Sodium Tablets Revenue by Application (2020-2031)
10.2.2 China Levothyroxine Sodium Tablets Sales by Application (2020-2031)
10.2.3 China Levothyroxine Sodium Tablets Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Levothyroxine Sodium Tablets Market Size by Type
11.1.1 Asia Levothyroxine Sodium Tablets Revenue by Type (2020-2031)
11.1.2 Asia Levothyroxine Sodium Tablets Sales by Type (2020-2031)
11.1.3 Asia Levothyroxine Sodium Tablets Price by Type (2020-2031)
11.2 Asia Levothyroxine Sodium Tablets Market Size by Application
11.2.1 Asia Levothyroxine Sodium Tablets Revenue by Application (2020-2031)
11.2.2 Asia Levothyroxine Sodium Tablets Sales by Application (2020-2031)
11.2.3 Asia Levothyroxine Sodium Tablets Price by Application (2020-2031)
11.3 Asia Levothyroxine Sodium Tablets Market Size by Country
11.3.1 Asia Levothyroxine Sodium Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Levothyroxine Sodium Tablets Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Levothyroxine Sodium Tablets Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Levothyroxine Sodium Tablets Market Size by Type
12.1.1 SAMEA Levothyroxine Sodium Tablets Revenue by Type (2020-2031)
12.1.2 SAMEA Levothyroxine Sodium Tablets Sales by Type (2020-2031)
12.1.3 SAMEA Levothyroxine Sodium Tablets Price by Type (2020-2031)
12.2 SAMEA Levothyroxine Sodium Tablets Market Size by Application
12.2.1 SAMEA Levothyroxine Sodium Tablets Revenue by Application (2020-2031)
12.2.2 SAMEA Levothyroxine Sodium Tablets Sales by Application (2020-2031)
12.2.3 SAMEA Levothyroxine Sodium Tablets Price by Application (2020-2031)
12.3 SAMEA Levothyroxine Sodium Tablets Market Size by Country
12.3.1 SAMEA Levothyroxine Sodium Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Levothyroxine Sodium Tablets Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Levothyroxine Sodium Tablets Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Levothyroxine Sodium Tablets Value Chain Analysis
13.1.1 Levothyroxine Sodium Tablets Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Levothyroxine Sodium Tablets Production Mode & Process
13.2 Levothyroxine Sodium Tablets Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Levothyroxine Sodium Tablets Distributors
13.2.3 Levothyroxine Sodium Tablets Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.